Dove is developed by Conopco, Inc. d/b/a Unilever.

What development phase is Dove in?

Dove is FDA-approved (marketed).

What is the generic name of Dove?

LIME is the generic (nonproprietary) name of Dove.

Last reviewed 2026-04-20 · How we verify

Dove (LIME)

Conopco, Inc. d/b/a Unilever · FDA-approved active Small molecule Quality 6/100

At a glance

Generic name	LIME
Sponsor	Conopco, Inc. d/b/a Unilever
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers (NA)
Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy (NA)
Impact of CO2 Absorption on Gas Exchange and Ventilation Patterns While Breathing Into a Snow Air Pocket (NA)
Effects of Mobilization With Movement Floss Band (MWF) Application (NA)
Structural Heat Adaptation and Education in Rural Setting (NA)
Structural Heat Adaptation and Education in Urban Setting (NA)
A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a 12 Months Clinical Study (NA)
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dove CI brief — competitive landscape report
Dove updates RSS · CI watch RSS
Conopco, Inc. d/b/a Unilever portfolio CI